BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 17725689)

  • 41. An infectious conspiracy: the case for HSV-1 and APOEepsilon4 in Alzheimer's disease.
    Federoff HJ
    Neurobiol Aging; 1999; 20(4):467-8. PubMed ID: 10604442
    [No Abstract]   [Full Text] [Related]  

  • 42. Apolipoprotein E alleles can contribute to the pathogenesis of numerous clinical conditions including HSV-1 corneal disease.
    Hill JM; Bhattacharjee PS; Neumann DM
    Exp Eye Res; 2007 May; 84(5):801-11. PubMed ID: 17007837
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Herpes simplex virus type 1 as risk factor associated to Alzheimer disease].
    Martin C; Solís L; Concha MI; Otth C
    Rev Med Chil; 2011 Jun; 139(6):779-86. PubMed ID: 22051760
    [TBL] [Abstract][Full Text] [Related]  

  • 44. HSV-1 in brain and risk of Alzheimer's disease.
    Beffert U; Bertrand P; Champagne D; Gauthier S; Poirier J
    Lancet; 1998 May; 351(9112):1330-1. PubMed ID: 9643802
    [No Abstract]   [Full Text] [Related]  

  • 45. Herpes Viruses Increase the Risk of Alzheimer's Disease: A Meta-Analysis.
    Steel AJ; Eslick GD
    J Alzheimers Dis; 2015; 47(2):351-64. PubMed ID: 26401558
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Apolipoprotein E genotype and alpha-tocopherol modulate amyloid precursor protein metabolism and cell cycle regulation.
    Huebbe P; Schaffer S; Jofre-Monseny L; Boesch-Saadatmandi C; Minihane AM; Müller WE; Eckert GP; Rimbach G
    Mol Nutr Food Res; 2007 Dec; 51(12):1510-7. PubMed ID: 18030662
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Senile plaques in Alzheimer's diseased brains: possible association of beta-amyloid with herpes simplex virus type 1 (HSV-1) L-particles.
    Kammerman EM; Neumann DM; Ball MJ; Lukiw W; Hill JM
    Med Hypotheses; 2006; 66(2):294-9. PubMed ID: 16242250
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of the brain-derived neurotrophic factor and the apolipoprotein E polymorphisms on disease progression in preclinical Alzheimer's disease.
    Hashimoto R; Hirata Y; Asada T; Yamashita F; Nemoto K; Mori T; Moriguchi Y; Kunugi H; Arima K; Ohnishi T
    Genes Brain Behav; 2009 Feb; 8(1):43-52. PubMed ID: 18786162
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Lack of association between HSV-1 DNA in the brain, Alzheimer's disease and apolipoprotein E4.
    Marques AR; Straus SE; Fahle G; Weir S; Csako G; Fischer SH
    J Neurovirol; 2001 Feb; 7(1):82-3. PubMed ID: 11519487
    [No Abstract]   [Full Text] [Related]  

  • 50. Alzheimer's disease and herpes.
    Itzhaki RF; Dobson CB
    CMAJ; 2002 Jul; 167(1):13. PubMed ID: 12137067
    [No Abstract]   [Full Text] [Related]  

  • 51. Herpes simplex virus type 1 and Alzheimer's disease: link and potential impact on treatment.
    Mancuso R; Sicurella M; Agostini S; Marconi P; Clerici M
    Expert Rev Anti Infect Ther; 2019 Sep; 17(9):715-731. PubMed ID: 31414935
    [No Abstract]   [Full Text] [Related]  

  • 52. Role of BDNF Val66Met functional polymorphism in Alzheimer's disease-related depression.
    Borroni B; Archetti S; Costanzi C; Grassi M; Ferrari M; Radeghieri A; Caimi L; Caltagirone C; Di Luca M; Padovani A;
    Neurobiol Aging; 2009 Sep; 30(9):1406-12. PubMed ID: 18179845
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Early acquisition of herpes simplex virus type 1 antibodies in children--a longitudinal serological study.
    Tunbäck P; Bergström T; Claesson BA; Carlsson RM; Löwhagen GB
    J Clin Virol; 2007 Sep; 40(1):26-30. PubMed ID: 17644470
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Risk factors for herpes simplex virus transmission to pregnant women: a couples study.
    Baker DA
    Am J Obstet Gynecol; 2005 Dec; 193(6):1887-8. PubMed ID: 16325587
    [No Abstract]   [Full Text] [Related]  

  • 55. Pharmacogenomics in Alzheimer's disease.
    Cacabelos R
    Methods Mol Biol; 2008; 448():213-357. PubMed ID: 18370236
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Apolipoprotein E, amyloid, and Alzheimer disease.
    Bales KR; Dodart JC; DeMattos RB; Holtzman DM; Paul SM
    Mol Interv; 2002 Oct; 2(6):363-75, 339. PubMed ID: 14993413
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Challenges and directions for the pathogen hypothesis of Alzheimer's disease.
    Robinson SR; Dobson C; Lyons J
    Neurobiol Aging; 2004; 25(5):629-37. PubMed ID: 15172741
    [TBL] [Abstract][Full Text] [Related]  

  • 58. PCR search for the herpes simplex virus type 1 genome in brain sections of patients with familial Alzheimer's disease.
    Mori I; Yokochi T; Koide N; Sugiyama T; Yoshida T; Kimura Y; Naiki H; Matsubara R; Takeuchi T; Nishiyama Y
    J Clin Microbiol; 2004 Feb; 42(2):936-7. PubMed ID: 14766896
    [No Abstract]   [Full Text] [Related]  

  • 59. Apolipoprotein E genotype and hepatitis C, HIV and herpes simplex disease risk: a literature review.
    Kuhlmann I; Minihane AM; Huebbe P; Nebel A; Rimbach G
    Lipids Health Dis; 2010 Jan; 9():8. PubMed ID: 20109174
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Aging-related neurostructural, neuropathological, and behavioral changes associated with herpes simplex virus type 1 brain infection in mice.
    Guzman-Sanchez F; Valdivieso F; Burgos JS
    J Alzheimers Dis; 2012; 30(4):779-90. PubMed ID: 22466000
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.